BlackRock Investment Management, LLC - CHEMBIO DIAGNOSTICS INC ownership

CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 26 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CHEMBIO DIAGNOSTICS INC
ValueSharesWeighting
Q4 2016$13,000
-7.1%
1,8560.0%0.00%
Q3 2016$14,000
+7.7%
1,856
+17.5%
0.00%
Q2 2016$13,000
+18.2%
1,580
-12.5%
0.00%
Q1 2016$11,000
+10.0%
1,8050.0%0.00%
Q4 2015$10,000
+66.7%
1,805
+13.5%
0.00%
Q3 2015$6,000
-25.0%
1,5900.0%0.00%
Q2 2015$8,000
+14.3%
1,590
-7.6%
0.00%
Q1 2015$7,000
+16.7%
1,720
+21.5%
0.00%
Q4 2014$6,000
+20.0%
1,4160.0%0.00%
Q3 2014$5,0000.0%1,4160.0%0.00%
Q2 2014$5,0001,4160.00%
Other shareholders
CHEMBIO DIAGNOSTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Penbrook Management LLC 344,060$1,634,0001.26%
Union Square Park Capital Management, LLC 400,000$1,900,0000.76%
P.A.W. CAPITAL CORP 100,000$475,0000.42%
PRECEPT MANAGEMENT LLC 150,000$713,0000.29%
Newbridge Financial Services Group, Inc. 73,500$349,0000.29%
SANDERS MORRIS HARRIS LLC 183,584$990,0000.22%
FRIESS ASSOCIATES LLC 555,000$2,636,0000.19%
PERRITT CAPITAL MANAGEMENT INC 30,651$146,0000.09%
Ikarian Capital, LLC 219,109$1,041,0000.05%
SEGALL BRYANT & HAMILL, LLC 705,823$3,352,0000.04%
View complete list of CHEMBIO DIAGNOSTICS INC shareholders